APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ringworm Treatment

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Ringworm Treatment Market Outlook and Growth Opportunities 2026

30 December 2025193 pages

Choose your research edition.

Industry ResearchRingworm Treatment Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Ringworm Treatment Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Ringworm Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ringworm Treatment Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Ringworm Treatment Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Ringworm Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Ringworm Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ringworm Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ringworm Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Ringworm Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Ringworm Treatment market include Bausch Health, GlaxoSmithKline, Glenmark Pharmaceuticals, Merz Pharma, Perrigo Company, Quinnova Pharmaceuticals, Taro Pharmaceutical, Teva Pharmaceuticals and Novartis, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Ringworm Treatment market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ringworm Treatment and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ringworm Treatment revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Ringworm Treatment market.

Ringworm Treatment Segment by Company

Bausch Health

GlaxoSmithKline

Glenmark Pharmaceuticals

Merz Pharma

Perrigo Company

Quinnova Pharmaceuticals

Taro Pharmaceutical

Teva Pharmaceuticals

Novartis

Sun Pharmaceutical

Ringworm Treatment Segment by Type

Anti-Infectives

Antifungals

Steroids

Others

Ringworm Treatment Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Ringworm Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Ringworm Treatment status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Ringworm Treatment key companies, revenue, market share, and recent developments.

3. To split the Ringworm Treatment breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Ringworm Treatment market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Ringworm Treatment significant trends, drivers, influence factors in global and regions.

6. To analyze Ringworm Treatment competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ringworm Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ringworm Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ringworm Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ringworm Treatment industry.

Chapter 3: Detailed analysis of Ringworm Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Ringworm Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Ringworm Treatment in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Ringworm Treatment Industry Trends Table 2. Ringworm Treatment Industry Drivers Table 3. Ringworm Treatment Industry Opportunities and Challenges Table 4. Ringworm Treatment Industry Restraints Table 5. Global Ringworm Treatment Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Ringworm Treatment Revenue Share by Company (2021-2026) Table 7. Global Ringworm Treatment Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Ringworm Treatment Key Company Manufacturing Base & Headquarters Table 9. Global Ringworm Treatment Company, Product Type & Application Table 10. Global Ringworm Treatment Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Ringworm Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Anti-Infectives Table 15. Significant Companies of Antifungals Table 16. Significant Companies of Steroids Table 17. Significant Companies of Others Table 18. Global Ringworm Treatment Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Ringworm Treatment Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Ringworm Treatment Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Ringworm Treatment Sales Value Share by Type (2021-2026) Table 22. Global Ringworm Treatment Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Retail Pharmacies Table 24. Significant Companies of Online Pharmacies Table 25. Significant Companies of Hospital Pharmacies Table 26. Global Ringworm Treatment Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Ringworm Treatment Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Ringworm Treatment Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Ringworm Treatment Sales Value Share by Application (2021-2026) Table 30. Global Ringworm Treatment Sales Value Share by Application (2027-2032) Table 31. Global Ringworm Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Ringworm Treatment Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Ringworm Treatment Sales Value Share by Region (2021-2026) Table 34. Global Ringworm Treatment Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Ringworm Treatment Sales Value Share by Region (2027-2032) Table 36. Global Ringworm Treatment Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Ringworm Treatment Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Ringworm Treatment Sales Value Market Share by Country (2021-2026) Table 39. Global Ringworm Treatment Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Ringworm Treatment Sales Value Market Share by Country (2027-2032) Table 41. Bausch Health Company Information Table 42. Bausch Health Business Overview Table 43. Bausch Health Ringworm Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Bausch Health Ringworm Treatment Product Portfolio Table 45. Bausch Health Recent Development Table 46. GlaxoSmithKline Company Information Table 47. GlaxoSmithKline Business Overview Table 48. GlaxoSmithKline Ringworm Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. GlaxoSmithKline Ringworm Treatment Product Portfolio Table 50. GlaxoSmithKline Recent Development Table 51. Glenmark Pharmaceuticals Company Information Table 52. Glenmark Pharmaceuticals Business Overview Table 53. Glenmark Pharmaceuticals Ringworm Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Glenmark Pharmaceuticals Ringworm Treatment Product Portfolio Table 55. Glenmark Pharmaceuticals Recent Development Table 56. Merz Pharma Company Information Table 57. Merz Pharma Business Overview Table 58. Merz Pharma Ringworm Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Merz Pharma Ringworm Treatment Product Portfolio Table 60. Merz Pharma Recent Development Table 61. Perrigo Company Company Information Table 62. Perrigo Company Business Overview Table 63. Perrigo Company Ringworm Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Perrigo Company Ringworm Treatment Product Portfolio Table 65. Perrigo Company Recent Development Table 66. Quinnova Pharmaceuticals Company Information Table 67. Quinnova Pharmaceuticals Business Overview Table 68. Quinnova Pharmaceuticals Ringworm Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Quinnova Pharmaceuticals Ringworm Treatment Product Portfolio Table 70. Quinnova Pharmaceuticals Recent Development Table 71. Taro Pharmaceutical Company Information Table 72. Taro Pharmaceutical Business Overview Table 73. Taro Pharmaceutical Ringworm Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Taro Pharmaceutical Ringworm Treatment Product Portfolio Table 75. Taro Pharmaceutical Recent Development Table 76. Teva Pharmaceuticals Company Information Table 77. Teva Pharmaceuticals Business Overview Table 78. Teva Pharmaceuticals Ringworm Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Teva Pharmaceuticals Ringworm Treatment Product Portfolio Table 80. Teva Pharmaceuticals Recent Development Table 81. Novartis Company Information Table 82. Novartis Business Overview Table 83. Novartis Ringworm Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Novartis Ringworm Treatment Product Portfolio Table 85. Novartis Recent Development Table 86. Sun Pharmaceutical Company Information Table 87. Sun Pharmaceutical Business Overview Table 88. Sun Pharmaceutical Ringworm Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Sun Pharmaceutical Ringworm Treatment Product Portfolio Table 90. Sun Pharmaceutical Recent Development Table 91. Research Programs/Design for This Report Table 92. Authors List of This Report Table 93. Secondary Sources Table 94. Primary Sources List of Figures Figure 1. Ringworm Treatment Product Image Figure 2. Global Ringworm Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ringworm Treatment Market Size (2021-2032) & (US$ Million) Figure 4. Global Ringworm Treatment Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Anti-Infectives Image Figure 8. Antifungals Image Figure 9. Steroids Image Figure 10. Others Image Figure 11. Global Ringworm Treatment Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Ringworm Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Ringworm Treatment Sales Value Share by Type (2021-2032) Figure 14. Retail Pharmacies Image Figure 15. Online Pharmacies Image Figure 16. Hospital Pharmacies Image Figure 17. Global Ringworm Treatment Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Ringworm Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Ringworm Treatment Sales Value Share by Application (2021-2032) Figure 20. Global Ringworm Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Ringworm Treatment Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Ringworm Treatment Sales Value (2021-2032) & (US$ Million) Figure 23. North America Ringworm Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Ringworm Treatment Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Ringworm Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Ringworm Treatment Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Ringworm Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Ringworm Treatment Sales Value (2021-2032) & (US$ Million) Figure 29. South America Ringworm Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Ringworm Treatment Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Ringworm Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Ringworm Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Ringworm Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Ringworm Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Ringworm Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Ringworm Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Ringworm Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Ringworm Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Ringworm Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Ringworm Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Ringworm Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Ringworm Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Ringworm Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Ringworm Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Ringworm Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Ringworm Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Ringworm Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Ringworm Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Ringworm Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Ringworm Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Ringworm Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Ringworm Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Ringworm Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Ringworm Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Ringworm Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Ringworm Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Ringworm Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Ringworm Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Ringworm Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Ringworm Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Ringworm Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Ringworm Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Ringworm Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Ringworm Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Ringworm Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Ringworm Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Ringworm Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Ringworm Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Ringworm Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Ringworm Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Ringworm Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Ringworm Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Ringworm Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Ringworm Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Ringworm Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Ringworm Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Ringworm Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Ringworm Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Ringworm Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Ringworm Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Ringworm Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Ringworm Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Ringworm Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Ringworm Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Ringworm Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Ringworm Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Ringworm Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Ringworm Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Ringworm Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Ringworm Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Ringworm Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Ringworm Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Ringworm Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Ringworm Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Ringworm Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Ringworm Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Ringworm Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Ringworm Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Ringworm Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Ringworm Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Ringworm Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Ringworm Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Ringworm Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Ringworm Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Ringworm Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Ringworm Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Ringworm Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Ringworm Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Ringworm Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Ringworm Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Ringworm Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Ringworm Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Ringworm Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Ringworm Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Ringworm Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Anti-Infectives
  • Antifungals
  • Steroids
  • Others
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Bausch Health
  • GlaxoSmithKline
  • Glenmark Pharmaceuticals
  • Merz Pharma
  • Perrigo Company
  • Quinnova Pharmaceuticals
  • Taro Pharmaceutical
  • Teva Pharmaceuticals
  • Novartis
  • Sun Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Ringworm Treatment Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Ringworm Treatment Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Ringworm Treatment Market Dynamics
  1. 2.1 Ringworm Treatment Industry Trends
  2. 2.2 Ringworm Treatment Industry Drivers
  3. 2.3 Ringworm Treatment Industry Opportunities and Challenges
  4. 2.4 Ringworm Treatment Industry Restraints
3 Ringworm Treatment Market by Company
  1. 3.1 Global Ringworm Treatment Company Revenue Ranking in 2025
  2. 3.2 Global Ringworm Treatment Revenue by Company (2021-2026)
  3. 3.3 Global Ringworm Treatment Company Ranking (2024-2026)
  4. 3.4 Global Ringworm Treatment Company Manufacturing Base and Headquarters
  5. 3.5 Global Ringworm Treatment Company Product Type and Application
  6. 3.6 Global Ringworm Treatment Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Ringworm Treatment Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Ringworm Treatment Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Ringworm Treatment Market by Type
  1. 4.1 Ringworm Treatment Type Introduction
  2. 4.1.1 Anti-Infectives
  3. 4.1.2 Antifungals
  4. 4.1.3 Steroids
  5. 4.1.4 Others
  6. 4.2 Global Ringworm Treatment Sales Value by Type
  7. 4.2.1 Global Ringworm Treatment Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Ringworm Treatment Sales Value by Type (2021-2032)
  9. 4.2.3 Global Ringworm Treatment Sales Value Share by Type (2021-2032)
5 Ringworm Treatment Market by Application
  1. 5.1 Ringworm Treatment Application Introduction
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Hospital Pharmacies
  5. 5.2 Global Ringworm Treatment Sales Value by Application
  6. 5.2.1 Global Ringworm Treatment Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ringworm Treatment Sales Value by Application (2021-2032)
  8. 5.2.3 Global Ringworm Treatment Sales Value Share by Application (2021-2032)
6 Ringworm Treatment Regional Value Analysis
  1. 6.1 Global Ringworm Treatment Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ringworm Treatment Sales Value by Region (2021-2032)
  3. 6.2.1 Global Ringworm Treatment Sales Value by Region: 2021-2026
  4. 6.2.2 Global Ringworm Treatment Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Ringworm Treatment Sales Value (2021-2032)
  7. 6.3.2 North America Ringworm Treatment Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Ringworm Treatment Sales Value (2021-2032)
  10. 6.4.2 Europe Ringworm Treatment Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Ringworm Treatment Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Ringworm Treatment Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Ringworm Treatment Sales Value (2021-2032)
  16. 6.6.2 South America Ringworm Treatment Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Ringworm Treatment Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Ringworm Treatment Sales Value Share by Country, 2025 VS 2032
7 Ringworm Treatment Country-level Value Analysis
  1. 7.1 Global Ringworm Treatment Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Ringworm Treatment Sales Value by Country (2021-2032)
  3. 7.2.1 Global Ringworm Treatment Sales Value by Country (2021-2026)
  4. 7.2.2 Global Ringworm Treatment Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Ringworm Treatment Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Ringworm Treatment Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Ringworm Treatment Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Ringworm Treatment Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Ringworm Treatment Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Ringworm Treatment Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Ringworm Treatment Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Ringworm Treatment Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Ringworm Treatment Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Ringworm Treatment Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Ringworm Treatment Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Ringworm Treatment Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Ringworm Treatment Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Ringworm Treatment Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Ringworm Treatment Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Ringworm Treatment Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Ringworm Treatment Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Ringworm Treatment Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Ringworm Treatment Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Ringworm Treatment Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Ringworm Treatment Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Ringworm Treatment Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Ringworm Treatment Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Ringworm Treatment Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Ringworm Treatment Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Ringworm Treatment Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Ringworm Treatment Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Ringworm Treatment Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Ringworm Treatment Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Ringworm Treatment Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Ringworm Treatment Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Ringworm Treatment Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Ringworm Treatment Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Ringworm Treatment Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Ringworm Treatment Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Ringworm Treatment Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Ringworm Treatment Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Ringworm Treatment Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Ringworm Treatment Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Ringworm Treatment Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Ringworm Treatment Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Ringworm Treatment Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Ringworm Treatment Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Ringworm Treatment Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Ringworm Treatment Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Ringworm Treatment Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Ringworm Treatment Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Ringworm Treatment Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Ringworm Treatment Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Ringworm Treatment Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Ringworm Treatment Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Ringworm Treatment Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Ringworm Treatment Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Ringworm Treatment Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Ringworm Treatment Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Ringworm Treatment Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Ringworm Treatment Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Ringworm Treatment Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Ringworm Treatment Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Ringworm Treatment Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Ringworm Treatment Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Ringworm Treatment Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Ringworm Treatment Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Ringworm Treatment Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Ringworm Treatment Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Ringworm Treatment Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Ringworm Treatment Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Ringworm Treatment Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Ringworm Treatment Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Ringworm Treatment Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Ringworm Treatment Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Ringworm Treatment Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Ringworm Treatment Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Ringworm Treatment Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Ringworm Treatment Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Ringworm Treatment Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Ringworm Treatment Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Ringworm Treatment Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Ringworm Treatment Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Ringworm Treatment Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Ringworm Treatment Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Ringworm Treatment Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Ringworm Treatment Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Ringworm Treatment Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bausch Health
  2. 8.1.1 Bausch Health Company Information
  3. 8.1.2 Bausch Health Business Overview
  4. 8.1.3 Bausch Health Ringworm Treatment Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Bausch Health Ringworm Treatment Product Portfolio
  6. 8.1.5 Bausch Health Recent Developments
  7. 8.2 GlaxoSmithKline
  8. 8.2.1 GlaxoSmithKline Company Information
  9. 8.2.2 GlaxoSmithKline Business Overview
  10. 8.2.3 GlaxoSmithKline Ringworm Treatment Revenue and Gross Margin (2021-2026)
  11. 8.2.4 GlaxoSmithKline Ringworm Treatment Product Portfolio
  12. 8.2.5 GlaxoSmithKline Recent Developments
  13. 8.3 Glenmark Pharmaceuticals
  14. 8.3.1 Glenmark Pharmaceuticals Company Information
  15. 8.3.2 Glenmark Pharmaceuticals Business Overview
  16. 8.3.3 Glenmark Pharmaceuticals Ringworm Treatment Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Glenmark Pharmaceuticals Ringworm Treatment Product Portfolio
  18. 8.3.5 Glenmark Pharmaceuticals Recent Developments
  19. 8.4 Merz Pharma
  20. 8.4.1 Merz Pharma Company Information
  21. 8.4.2 Merz Pharma Business Overview
  22. 8.4.3 Merz Pharma Ringworm Treatment Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Merz Pharma Ringworm Treatment Product Portfolio
  24. 8.4.5 Merz Pharma Recent Developments
  25. 8.5 Perrigo Company
  26. 8.5.1 Perrigo Company Company Information
  27. 8.5.2 Perrigo Company Business Overview
  28. 8.5.3 Perrigo Company Ringworm Treatment Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Perrigo Company Ringworm Treatment Product Portfolio
  30. 8.5.5 Perrigo Company Recent Developments
  31. 8.6 Quinnova Pharmaceuticals
  32. 8.6.1 Quinnova Pharmaceuticals Company Information
  33. 8.6.2 Quinnova Pharmaceuticals Business Overview
  34. 8.6.3 Quinnova Pharmaceuticals Ringworm Treatment Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Quinnova Pharmaceuticals Ringworm Treatment Product Portfolio
  36. 8.6.5 Quinnova Pharmaceuticals Recent Developments
  37. 8.7 Taro Pharmaceutical
  38. 8.7.1 Taro Pharmaceutical Company Information
  39. 8.7.2 Taro Pharmaceutical Business Overview
  40. 8.7.3 Taro Pharmaceutical Ringworm Treatment Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Taro Pharmaceutical Ringworm Treatment Product Portfolio
  42. 8.7.5 Taro Pharmaceutical Recent Developments
  43. 8.8 Teva Pharmaceuticals
  44. 8.8.1 Teva Pharmaceuticals Company Information
  45. 8.8.2 Teva Pharmaceuticals Business Overview
  46. 8.8.3 Teva Pharmaceuticals Ringworm Treatment Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Teva Pharmaceuticals Ringworm Treatment Product Portfolio
  48. 8.8.5 Teva Pharmaceuticals Recent Developments
  49. 8.9 Novartis
  50. 8.9.1 Novartis Company Information
  51. 8.9.2 Novartis Business Overview
  52. 8.9.3 Novartis Ringworm Treatment Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Novartis Ringworm Treatment Product Portfolio
  54. 8.9.5 Novartis Recent Developments
  55. 8.10 Sun Pharmaceutical
  56. 8.10.1 Sun Pharmaceutical Company Information
  57. 8.10.2 Sun Pharmaceutical Business Overview
  58. 8.10.3 Sun Pharmaceutical Ringworm Treatment Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sun Pharmaceutical Ringworm Treatment Product Portfolio
  60. 8.10.5 Sun Pharmaceutical Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst